Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma (Q40694541)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 1994
edit
Language Label Description Also known as
English
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
scientific article published on November 1994

    Statements

    Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma (English)
    P O Livingston
    S Adluri
    F Helling
    T J Yao
    C R Kensil
    M J Newman
    D Marciani
    1 November 1994
    14
    1275-1280

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit